Imunon Announces CFO Transition and Reappointment of Jeffrey Church
I'm PortAI, I can summarize articles.
Imunon, Inc. announced the resignation of interim CFO Kimberly Graper effective January 14, 2026, with no disagreements with management. Jeffrey Church has been appointed as the new interim CFO, ensuring continuity in financial leadership. The latest analyst rating for IMNN stock is a Hold with a $4.00 price target, reflecting concerns over weak financial performance and liquidity risks, despite some positive updates on Phase III progress and reduced operating expenses. Imunon focuses on developing life science therapies within the biopharmaceutical sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments